K. H. Wiedmann

1.1k total citations
33 papers, 815 citations indexed

About

K. H. Wiedmann is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, K. H. Wiedmann has authored 33 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 14 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in K. H. Wiedmann's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Diseases and Immunity (8 papers) and Hepatitis C virus research (6 papers). K. H. Wiedmann is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Diseases and Immunity (8 papers) and Hepatitis C virus research (6 papers). K. H. Wiedmann collaborates with scholars based in Germany, United Kingdom and Switzerland. K. H. Wiedmann's co-authors include P. A. Berg, Frank Seibold, P. Weber, Howard C. Thomas, Reinhild Klein, Alison H. Goodall, G Miescher, Luis F. Montaño, George Janossy and H Jenss and has published in prestigious journals such as The Lancet, Hepatology and Gut.

In The Last Decade

K. H. Wiedmann

32 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. H. Wiedmann Germany 13 396 348 201 142 142 33 815
T. Poralla Germany 19 382 1.0× 372 1.1× 220 1.1× 55 0.4× 168 1.2× 56 973
Hidehiro Murakami Japan 19 316 0.8× 266 0.8× 222 1.1× 59 0.4× 395 2.8× 50 921
Dolores Fuentes Spain 12 448 1.1× 215 0.6× 251 1.2× 293 2.1× 250 1.8× 15 839
Henrik Gjertsen Sweden 14 314 0.8× 113 0.3× 223 1.1× 269 1.9× 108 0.8× 28 766
Robert Przemioslo United Kingdom 16 468 1.2× 95 0.3× 375 1.9× 493 3.5× 155 1.1× 32 886
A Dasgupta United States 11 168 0.4× 78 0.2× 99 0.5× 76 0.5× 137 1.0× 16 482
Guo–Xiang Yang United States 18 573 1.4× 772 2.2× 378 1.9× 27 0.2× 401 2.8× 18 1.3k
P. RUTGEERTS Belgium 14 363 0.9× 42 0.1× 253 1.3× 118 0.8× 136 1.0× 15 759
N.B. Hershfield Canada 15 200 0.5× 72 0.2× 343 1.7× 97 0.7× 29 0.2× 35 698
G. Heuschen Germany 13 415 1.0× 60 0.2× 500 2.5× 97 0.7× 81 0.6× 23 946

Countries citing papers authored by K. H. Wiedmann

Since Specialization
Citations

This map shows the geographic impact of K. H. Wiedmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. H. Wiedmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. H. Wiedmann more than expected).

Fields of papers citing papers by K. H. Wiedmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. H. Wiedmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. H. Wiedmann. The network helps show where K. H. Wiedmann may publish in the future.

Co-authorship network of co-authors of K. H. Wiedmann

This figure shows the co-authorship network connecting the top 25 collaborators of K. H. Wiedmann. A scholar is included among the top collaborators of K. H. Wiedmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. H. Wiedmann. K. H. Wiedmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiedmann, K. H., Claudia Bartels, Norbert Scherbaum, et al.. (2019). Lebensqualität und Depression bei Hörminderung: Eine deutsche Bedarfsanalyse. HNO. 67(1). 36–44. 1 indexed citations
2.
Wiedmann, K. H., Claudia Bartels, Norbert Scherbaum, et al.. (2018). Lebensqualität und Depression bei Hörminderung. HNO. 67(1). 36–44. 5 indexed citations
3.
4.
Weber, P., M Scheurlen, & K. H. Wiedmann. (2008). Methotrexat in der Therapie der primären biliären Zirrhose*. DMW - Deutsche Medizinische Wochenschrift. 116(36). 1347–1352. 1 indexed citations
5.
Glück, T., et al.. (2008). Hepatitis-B-assoziierte Vaskulitis: Verlauf unter Therapie mit Glucocorticoiden und α-Interferon. DMW - Deutsche Medizinische Wochenschrift. 119(41). 1388–1392. 4 indexed citations
6.
Witthöft, T, B Möller, K. H. Wiedmann, et al.. (2007). Safety, tolerability and efficacy of peginterferon alpha‐2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial. Journal of Viral Hepatitis. 14(11). 788–796. 44 indexed citations
7.
Manns, Michael P., et al.. (2004). Standardtherapie der chronischen Hepatitis B. Zeitschrift für Gastroenterologie. 42(8). 687–691.
8.
Turi, Stefano, et al.. (2004). Dünndarmlipom. Zeitschrift für Gastroenterologie. 42(2). 147–151. 4 indexed citations
9.
Teuber, G, M. Pascu, Thomas Berg, et al.. (2003). Randomized, controlled trial with IFN-α combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C. Journal of Hepatology. 39(4). 606–613. 34 indexed citations
10.
Beuers, Ulrich, K. H. Wiedmann, G. Kleber, & Wolfgang E. Fleig. (1998). Treatment of autoimmune hepatitis, primarily biliary cirrhosis and primary sclerosing cholangitis - Consensus report of the German Society for Gastrointestinal and Metabolic Disorders (vol 35, pg 1041, 1997). Zeitschrift für Gastroenterologie. 36(1). 2 indexed citations
11.
12.
Beuers, Ulrich, K. H. Wiedmann, G. Kleber, & Wolfgang E. Fleig. (1997). [Therapy of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis. Consensus of the German Society of Digestive System and Metabolic Diseases].. PubMed. 35(12). 1041–9. 7 indexed citations
13.
Seibold, Frank, P. Weber, Reinhild Klein, P. A. Berg, & K. H. Wiedmann. (1992). Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.. Gut. 33(5). 657–662. 148 indexed citations
14.
Seibold, Frank, P. Weber, H Jenss, & K. H. Wiedmann. (1991). Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease.. Gut. 32(10). 1192–1197. 77 indexed citations
15.
Paulus, Werner, et al.. (1990). Immunohistochemical demonstration of mitochondria in routinely processed tissue using a monoclonal antibody. The Journal of Pathology. 160(4). 321–328. 5 indexed citations
16.
Wiedmann, K. H., L K Trejdosiewicz, Alison H. Goodall, & Heath C. Thomas. (1985). Analysis of the antigenic composition of liver specific lipoprotein using murine monoclonal antibodies.. Gut. 26(5). 510–517. 8 indexed citations
17.
Wiedmann, K. H., Guoqing Diao, W Dölle, et al.. (1985). SERUM INHIBITORY FACTORS (SIF) ARE OF PROGNOSTIC VALUE IN ACUTE VIRAL HEPATITIS. The Lancet. 325(8424). 309–312. 13 indexed citations
18.
Wiedmann, K. H., Arthur Melms, & P. A. Berg. (1983). Anti‐actin antibodies of IgM and IgG class in chronic liver diseases detected by fluorometric immunoassay*. Liver International. 3(6). 369–376. 10 indexed citations
19.
Frösner, Gert, et al.. (1982). Diagnostic significance of quantitative determination of hepatitis B surface antigen in acute and chronic hepatitis B infection. European Journal of Clinical Microbiology & Infectious Diseases. 1(1). 52–58. 32 indexed citations
20.
Wilms, K., et al.. (1979). Schwere megaloblastäre Anämie durch Triamteren bei einem Patienten mit alkoholischer Leberzirrhose. DMW - Deutsche Medizinische Wochenschrift. 104(22). 814–817. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Poralla Breakdown of academic impact, for papers by Hidehiro Murakami Breakdown of academic impact, for papers by Dolores Fuentes Breakdown of academic impact, for papers by Henrik Gjertsen Breakdown of academic impact, for papers by Robert Przemioslo Breakdown of academic impact, for papers by A Dasgupta Breakdown of academic impact, for papers by Guo–Xiang Yang Breakdown of academic impact, for papers by P. RUTGEERTS Breakdown of academic impact, for papers by N.B. Hershfield Breakdown of academic impact, for papers by G. Heuschen
Rankless by CCL
2026